Antonia Salud Salvia

Gasol Cudos, A.; Morales Murillo, S.; Panades Siurana, M. J.; Vilardell Villellas, F.; Canosa Morales, C.; Mele Olive, J.; Iglesias Martinez, E.; Salud Salvia, A.

Change in treatment decisions according to Oncotype Dx Recurrence Score in node positive and negative, estrogen-receptor positive (ER+), HER2 negative breast cancer in a single institution

BREAST 32 92-93. 01/03/2017.

Patel, UB; Brown, G; Machado, I; Santos-Cores, J; Pericay, C; Ballesteros, E; Salud, A; Isabel-Gil, M; Montagut, C; Maurel, J; Ramon-Ayuso, J; Martin, N; Estevan, R; Fernandez-Martos, C

MRI assessment and outcomes in patients receiving neoadjuvant chemotherapy only for primary rectal cancer: long-term results from the GEMCAD 0801 trial

ANNALS OF ONCOLOGY 28 344-353. 01/02/2017.

[doi:10.1093/annonc/mdw616]

Loupakis F; Stein A; Ychou M; Hermann F; Salud A; Österlund P

A Review of Clinical Studies and Practical Guide for the Administration of Triplet Chemotherapy Regimens with Bevacizumab in First-line Metastatic Colorectal Cancer

TARGETED ONCOLOGY 11 293-308. 01/06/2016.

[doi:10.1007/s11523-015-0400-y]

Porcel, JM; Esquerda, A; Martinez-Alonso, M; Bielsa, S; Salud, A

Identifying Thoracic Malignancies Through Pleural Fluid Biomarkers A Predictive Multivariate Model

Medicine 95 -. 01/03/2016.

[doi:10.1097/MD.0000000000003044]

Sastre J; Díaz-Beveridge R; García-Foncillas J; Guardeño R; López C; Pazo R; Rodriguez-Salas N; Salgado M; Salud A; Feliu J

Clinical guideline SEOM: hepatocellular carcinoma

CLINICAL & TRANSLATIONAL ONCOLOGY 17 988-995. 01/12/2015.

[doi:10.1007/s12094-015-1451-3]

Fernandez-Martos C; Garcia-Albeniz X; Pericay C; Maurel J; Aparicio J; Montagut C; Safont MJ; Salud A; Vera R; Massuti B; Escudero P; Alonso V; Bosch C; Martin M; Minsky BD

Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase II randomized trial

ANNALS OF ONCOLOGY 26 1722-1728. 01/08/2015.

[doi:10.1093/annonc/mdv223]

Porcel JM; Palma R; Bielsa S; Esquerda A; Gatius S; Matias-Guiu X; Salud A

TTF-1 and napsin A on cell blocks and supernatants of pleural fluids for labeling malignant effusions

RESPIROLOGY 20 831-833. 01/07/2015.

[doi:10.1111/resp.12543]

Porcel JM; Gasol A; Bielsa S; Civit C; Light RW; Salud A

Clinical features and survival of lung cancer patients with pleural effusions

RESPIROLOGY 20 654-659. 01/05/2015.

[doi:10.1111/resp.12496]

Garcia-Alfonso P; Chaves M; Muñoz A; Salud A; García-Gonzalez M; Grávalos C; Massuti B; González-Flores E; Queralt B; López-Ladrón A; Losa F; Gómez MJ; Oltra A; Aranda E

Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: the phase II AVAXIRI study

Bmc Cancer 15 327-327. 29/04/2015.

[doi:10.1186/s12885-015-1293-y]

Porcel JM; Hernández P; Martínez-Alonso M; Bielsa S; Salud A

Accuracy of Fluorodeoxyglucose-PET Imaging for Differentiating Benign From Malignant Pleural Effusions A Meta-analysis

Chest 147 502-512. 01/02/2015.

[doi:10.1378/chest.14-0820]

Feliu J; Salud A; Safont MJ; García-Girón C; Aparicio J; Losa F; Bosch C; Escudero P; Casado E; Jorge M; Bohn U; Pérez-Carrión R; Carmona A; Custodio AB; Maurel J

Correlation of Hypertension and Proteinuria with Outcome in Elderly Bevacizumab-Treated Patients with Metastatic Colorectal Cancer

PLOS ONE 10 -. 20/01/2015.

[doi:10.1371/journal.pone.0116527]

Fernandez-Plana J; Pericay C; Quintero G; Alonso V; Salud A; Mendez M; Salgado M; Saigi E; Cirera L

Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRAS metastatic colorectal cancer: final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study)

Bmc Cancer 14 865-865. 22/11/2014.

[doi:10.1186/1471-2407-14-865]